clinical trials

News

Practice-Changing Clinical Trials in Metastatic Colorectal Cancer

05/30/2020

Autumn J McRee, MD, associate professor of medicine, The University of North Carolina at Chapel Hill, presented on three clinical studies of targeted therapies in unique niches of metastatic colorectal cancer. The...

Autumn...

05/30/2020

Journal of Clinical Pathways

Interview

Providing Critical Clinical Trials to the Community: The ECHO Footprint

05/14/2020

Journal of Clinical Pathways spoke with Dinesh Kapur, MD, managing partner and director of clinical research, Eastern Connecticut Hematology and Oncology (ECHO) Associates, regarding the unique identity the practice...

...

05/14/2020

Journal of Clinical Pathways

All that Glitters is Not Gold: The Fate of the ISCHEMIA Trial

04/03/2020

Jen Devinney-Lavsa , BPharm, PharmD, FASCP;

Donna B. Fedus , MA;

Upon review and interrogation of the primary outcomes slide over the following days, we experienced a startling revelation, arriving at a diametrically opposite conclusion from the presented trial conclusion.

Upon review and interrogation of...

04/03/2020

Cath Lab Digest

Calcium Corner

Interpreting the VEST Trial: Are We Missing the Point?

09/03/2018

Rahul N. Doshi , MD, FACC, FHRS;

At the American College of Cardiology’s 67th Annual Scientific Session held earlier this year, Dr. Jeffrey Olgin presented the results of the Vest Prevention of Early Sudden Death Trial (VEST) at the Late-Breaking Clinical Trial session.1

At the American College of...

09/03/2018

Cath Lab Digest

Interview

A Novel Device to Prevent Neointimal Hyperplasia Restenosis: The DANCE and LIMBO Trials

03/15/2017

Jennifer Ford ;

VDM spoke with George Adams, MD, MHS, at the 43rd Annual VEITH Symposium regarding the ongoing DANCE and LIMBO trials.

VDM spoke with George Adams, MD,...

03/15/2017

Vascular Disease Management

AMP Update

LIBERTY 360° Study Presentation at AMP 2016 Reveals Hope for Rutherford-6 CLI Patients

10/06/2016

Zsuzsanna Igyarto , PhD;

Brad J. Martinsen , PhD;

Jihad A. Mustapha , MD, FACC, FSCAI;

Early findings in this novel, all-comers PAD study suggest that “watchful waiting” in Rutherford Class 2-3 and “primary amputation” in Rutherford Class 6 may not be necessary. Percutaneous vascular interventions can be successful in these...

Early findings in this novel,...

10/06/2016

Cath Lab Digest

Research in Review

Common Outcome Measures for Clinical Trials Are Improving, Study Shows

01/28/2016

JCP Editors

According to a new study, core outcome sets (COS) for clinical trials have become more structured, but there remains a need for greater transparency and public engagement in how COS are developed. Clinical trials...

...

01/28/2016

Journal of Clinical Pathways

EP Research

An Inside Look at Cardiovascular Research at the Intermountain Heart Institute

03/31/2015

Viet Le , PA-C, FACC, FAHA;

Sarah Young , BA;

The Intermountain Heart Institute, located in the middle of the Salt Lake Valley in Utah, is part of Intermountain Healthcare’s flagship hospital, Intermountain Medical Center.

The Intermountain Heart...

03/31/2015

EP Lab Digest

Commentary

Recommendations for Designing and Implementing Protocols for Advanced Technology Clinical Trials

01/10/2004

Gerit D. Mulder ;

01/10/2004

Wounds